Advertisement
Advertisement
U.S. Markets open in 3 hrs 23 mins
Advertisement
Advertisement
Advertisement
Advertisement

Awakn Life Sciences Corp. (AWKNF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.4400+0.0600 (+15.79%)
At close: 03:54PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3800
Open0.4380
BidN/A x N/A
AskN/A x N/A
Day's Range0.3800 - 0.5006
52 Week Range0.1701 - 1.5800
Volume111,680
Avg. Volume17,509
Market Cap15.2M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.5070
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
  • Newsfile

    Awakn Life Sciences Responds to OTC Markets Request on Recent Promotional Activity

    Toronto, Ontario--(Newsfile Corp. - February 8, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announces that it has been requested by OTC Markets Group Inc. ("OTC Markets") to issue this statement about promotional activity concerning its common stock.On February, 6, 2023, OTC Markets informed the Company that it became aware of ...

  • Newsfile

    Awakn Life Sciences Granted Fast-Track Designation from UK Regulator for Ketamine-Assisted Therapy for Alcohol Use Disorder

    Designation Aims to Accelerate Time to Market Toronto, Ontario--(Newsfile Corp. - February 7, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announces today the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has granted Awakn an Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for its proprie

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Green Thumb will have a conference call to discuss its Q4 and full 2022 earnings on February 28, 2023. High Tide Q4 revenue rose 14% to C$108 million. SNDL completed the acquisition of The Valens Company. Columbia Care opened new Cannabist dispensary in Hampton, Virginia. Key Takeaways; Psychedelic Sector Awakn’s lead […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exclusive.

Advertisement
Advertisement